An 8-week Full Face HUT Clinical Trial for HydroBoost (2.0/3.0)
An 8-week Full Face HUT Design, Single Center, Double Blinded, Controlled and Randomized Study to Evaluate Different Product Regimens' Performance on Protecting Skin With Resilience Under Tracked City Environmental Aggressors
Sponsor: Johnson & Johnson Pte Ltd
Listed as NCT03264677, this NA trial focuses on Adult Skin Healthy Signs and remains completed. Sponsored by Johnson & Johnson Pte Ltd, it has been updated 5 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Sep 2017 — Jun 2018 [monthly]
Completed NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Johnson & Johnson Pte Ltd
- Shanghai China-Norm Management Consulting co.,LTD
- Shanghai Skin Disease Hospital
For direct contact, visit the study record on ClinicalTrials.gov .